SCHEMBL13504477

SCHEMBL13504477

CC(C)(C)OC(=O)NC1CCC(Nc2cccc3nc(Nc4ccc(C#N)cc4)nn23)CC1

nearest known ligand 0.44

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 8/20 0.44
▸ JAK3 P52333 4/20 0.44
▸ DRD2 P14416 1/20 0.44
▸ JAK1 P23458 5/20 0.43
▸ PTK2 Q05397 3/20 0.42
▸ EGLN2 Q96KS0 2/20 0.41
▸ KDM4D Q6B0I6 3/20 0.40
▸ TNF P01375 1/20 0.40
▸ IRAK4 Q9NWZ3 1/20 0.40
▸ SYK P43405 1/20 0.39
▸ TTK P33981 1/20 0.39
▸ PDE4B Q07343 1/20 0.38
▸ KCNA3 P22001 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13504479 1.00 JAK2 (0.44) JAK2JAK3DRD2JAK1PTK2
SCHEMBL3303455 0.87 JAK2 (0.45) JAK2JAK3JAK1PTK2SYK
SCHEMBL3303459 0.87 JAK2 (0.45) JAK2JAK3JAK1PTK2SYK
SCHEMBL3309064 0.87 EGLN2 (0.43) JAK2JAK3JAK1PTK2EGLN2
SCHEMBL3309067 0.87 EGLN2 (0.43) JAK2JAK3JAK1PTK2EGLN2
SCHEMBL3308742 0.86 DRD2 (0.42) JAK2JAK3DRD2JAK1PTK2
SCHEMBL13504460 0.83 JAK2 (0.51) JAK2JAK3JAK1PTK2EGLN2
SCHEMBL13504459 0.83 JAK2 (0.51) JAK2JAK3JAK1PTK2EGLN2
SCHEMBL2144032 0.83 PIM1 (0.46) JAK2JAK3JAK1PTK2EGLN2
SCHEMBL2144028 0.83 PIM1 (0.46) JAK2JAK3JAK1PTK2EGLN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2344494-B1 AMINOTRIAZOLOPYRIDINES AND THEIR USE AS KINASE INHIBITORS SIGNAL PHARM LLC (US) 2016-04-20 — — EP disclosed
US-8299056-B2 Aminotriazolopyridines, compositions thereof, and methods of treatment therewith SIGNAL PHARMACEUTICALS, LLC (US) 2012-10-30 — — US disclosed
Send feedback